Hydromer (HYDI)

[pennypauly]

Hydromer and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients
GlobeNewswireApril 24, 2020, 12:43 PM PDT
CONCORD, NC, April 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hydromer (OTCQB: HYDI) announced today that it will be the exclusive coating supplier and manufacturing partner for N8 Medical’s CeraShield™ Endotracheal Tube. Health Canada has granted emergency use access marketing approval for the CeraShield™ Endotracheal Tube for all Canadian mechanically-ventilated COVID-19 patients.

N8's CeraShield™ tube has a patented anti-fouling coating to prevent deadly bacterial infections that frequently occur in ventilated patients. Conventional endotracheal tubes allow pathogenic bacteria to rapidly grow on the tube surfaces and are a source of infection that may lead to acute kidney injury, sepsis and death.

“N8’s CeraShield™ Endotracheal Tube may reduce secondary bacterial infections, save lives and expand ventilator resource capacity by getting patients off ventilators sooner,” said Ronald Bracken, N8’s President and Chief Operating Officer. “We are pleased that Health Canada is now allowing all hospitals to have access to this potentially life-saving technology.